NO170011C - Analogifremgangsmaate til fremstilling av propanolaminderivater - Google Patents

Analogifremgangsmaate til fremstilling av propanolaminderivater

Info

Publication number
NO170011C
NO170011C NO892387A NO892387A NO170011C NO 170011 C NO170011 C NO 170011C NO 892387 A NO892387 A NO 892387A NO 892387 A NO892387 A NO 892387A NO 170011 C NO170011 C NO 170011C
Authority
NO
Norway
Prior art keywords
derivatives
propanolamin
preparation
analogue procedure
analogue
Prior art date
Application number
NO892387A
Other languages
English (en)
Other versions
NO892387L (no
NO892387D0 (no
NO170011B (no
Inventor
Frank Kienzle
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO892387D0 publication Critical patent/NO892387D0/no
Publication of NO892387L publication Critical patent/NO892387L/no
Publication of NO170011B publication Critical patent/NO170011B/no
Publication of NO170011C publication Critical patent/NO170011C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/52—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Glass Compositions (AREA)
  • Gyroscopes (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO892387A 1988-06-10 1989-06-09 Analogifremgangsmaate til fremstilling av propanolaminderivater NO170011C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH224588 1988-06-10

Publications (4)

Publication Number Publication Date
NO892387D0 NO892387D0 (no) 1989-06-09
NO892387L NO892387L (no) 1989-12-11
NO170011B NO170011B (no) 1992-05-25
NO170011C true NO170011C (no) 1992-09-02

Family

ID=4229254

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892387A NO170011C (no) 1988-06-10 1989-06-09 Analogifremgangsmaate til fremstilling av propanolaminderivater

Country Status (20)

Country Link
US (1) US5045567A (no)
EP (1) EP0345591B1 (no)
JP (1) JPH0236158A (no)
KR (1) KR910000600A (no)
AT (1) ATE87610T1 (no)
AU (1) AU622907B2 (no)
DE (1) DE58903919D1 (no)
DK (1) DK284289A (no)
ES (1) ES2053866T3 (no)
FI (1) FI892341L (no)
HU (1) HUT55344A (no)
IE (1) IE891855L (no)
IL (1) IL90528A0 (no)
MC (1) MC2042A1 (no)
NO (1) NO170011C (no)
NZ (1) NZ229456A (no)
PH (1) PH26237A (no)
PT (1) PT90802B (no)
YU (1) YU118389A (no)
ZA (1) ZA894210B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
ATE268758T1 (de) * 1997-04-04 2004-06-15 Aventis Pharma Gmbh Hypolipidämische propanolaminderivate
DE19845402B4 (de) * 1998-10-02 2005-04-07 Aventis Pharma Deutschland Gmbh Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE19845405C2 (de) * 1998-10-02 2000-07-13 Aventis Pharma Gmbh Arylsubstituierte Propanolaminderivate und deren Verwendung
DE19845403B4 (de) * 1998-10-02 2005-02-10 Aventis Pharma Deutschland Gmbh Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7112938A (no) * 1970-09-30 1972-04-05
US3888829A (en) * 1971-06-25 1975-06-10 Sandoz Ag N,n'-bis(3-hydroxy-2-(3,4-dihydroxy-phenyl)-1-propyl)-aliphatic-diamines
CA1145767A (en) * 1978-07-03 1983-05-03 Jack Mills Phenethanolamines, compositions containing the same, and method for effecting weight control
DE3267406D1 (en) * 1981-07-11 1985-12-19 Beecham Group Plc Secondary phenyl ethanol amines and their pharmaceutical use
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
WO1984000956A1 (en) * 1982-08-27 1984-03-15 Beecham Group Plc Secondary arylethanolamines
DE3462789D1 (en) * 1983-08-17 1987-04-30 Beecham Group Plc 2-phenylethylamine derivatives
DE3466387D1 (en) * 1983-11-04 1987-10-29 Beecham Group Plc Tertiary amines
CA1249992A (en) * 1983-11-10 1989-02-14 Marcel Muller Oxazolidines
FR2588556B1 (fr) * 1985-10-11 1988-01-08 Sanofi Sa Derives du naphtalene substitues par un groupement (omega-amino) alcanol a activite antimicrobienne, leur preparation et les compositions les contenant
CA1287061C (en) * 1986-06-27 1991-07-30 F. Hoffmann-La Roche Ag Pyridine ethanolamine derivatives
EP0300290B1 (de) * 1987-07-21 1991-12-18 F. Hoffmann-La Roche Ag Phenoxypropanolamine

Also Published As

Publication number Publication date
PH26237A (en) 1992-04-01
US5045567A (en) 1991-09-03
PT90802B (pt) 1994-11-30
DK284289A (da) 1989-12-11
NO892387L (no) 1989-12-11
DE58903919D1 (en) 1993-05-06
FI892341A0 (fi) 1989-05-16
DK284289D0 (da) 1989-06-09
NZ229456A (en) 1992-02-25
ZA894210B (en) 1990-03-28
PT90802A (pt) 1989-12-29
ES2053866T3 (es) 1994-08-01
HUT55344A (en) 1991-05-28
ATE87610T1 (de) 1993-04-15
NO892387D0 (no) 1989-06-09
NO170011B (no) 1992-05-25
MC2042A1 (fr) 1990-05-30
AU622907B2 (en) 1992-04-30
EP0345591A1 (de) 1989-12-13
JPH0236158A (ja) 1990-02-06
KR910000600A (ko) 1991-01-29
EP0345591B1 (de) 1993-03-31
FI892341A7 (fi) 1989-12-11
YU118389A (en) 1991-06-30
IL90528A0 (en) 1990-01-18
FI892341L (fi) 1989-12-11
AU3602689A (en) 1989-12-14
IE891855L (en) 1989-12-10

Similar Documents

Publication Publication Date Title
DK0539448T3 (da) Levnedsmiddelsammensætninger og farmaceutiske sammensætninger indeholdende kortkædede, monoumættede fedtsyrer og fremgangsmåde til anvendelse
IL87488A0 (en) Pharmaceutical compositions for the topical treatment of conditions associated with photodamaged skin,comprising substituted propenyl phenyl derivatives
JPS5557572A (en) Diphenylbutyllpiperazinecarboxamide and carbothioamide*its acid addition salt*its manufacture and medical composition containing it
ES424434A1 (es) Un metodo para preparar una composicion alimenticia para rumiantes.
DE69429297D1 (de) Zusammensetzung zur Behandlung von Patienten mit Lebererkrankungen
PT85184A (en) Process for the preparation of pyridine ethanolamine derivatives and of pharmaceutical compositions containing the same
DK0455783T3 (da) Anvendelse af nervonsyre og langkædede fedtsyrer til behandlingen af demyeliniserende sygdomme
DK162883D0 (da) N-glucosylerede carboxylsyreamidderivater, fremgangsmade til fremstilling heraf samt deres anvendelse til pavirkning af organismens egen forsvarsmekanisme
KR870700599A (ko) 카르복실산유도체, 그의 제조방법, 이화합물을 함유한 약제조성물 및 그의 용도
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
ES499782A0 (es) Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
ATE87610T1 (de) Propanolaminderivate.
DE3068585D1 (en) Derivatives of 3,4,5-trihydroxypiperidine, processes for their preparation, and their use as medicines and in animal food
IL61989A0 (en) Phenyl piperazine derivatives of 1,3,4-oxadiazolylphenols,their preparation and pharmaceutical compositions containing them
ATE3033T1 (de) Derivate des 2-hydroxymethyl-3,4,5-trihydroxypiperidins, ihre herstellung und sie enthaltende arzneimittel.
ATE86974T1 (de) (2-cyan-2-oximinoacetyl)-aminosaeure-derivate.
EP0027928A3 (en) Piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrole-2-carboxylic acid esters, their preparation and pharmaceutical compositions containing them
IE822853L (en) 1-piperazino carboxylates
BR9406629A (pt) Composições antiacidas liquidas
HUT62474A (en) Process for producing veterinary composition with antiparasitic effect
SE7906080L (sv) Farmaceutisk komposition innehallande trimetoprim och n-etyl-sigma-pyridon-3-karboxylsyraderivat
EP0386603A3 (de) Bisphenäthanolamine
JPS57132868A (en) Preparation of food for storage